The present invention relates to stable liquid formulations of paracetamol for pharmaceutical use and to a method of preparation of stable paracetamol solutions.
The invention concerns the use of paracetamol in a composition as depigmenting and/or bleaching agent for human skin, hairs and/or hair, and a depigmenting composition containing paracetamol.
The nitrate esters of paracetamol are prepared by reacting the paracetamol with dihaloalkyl compound and followed by reaction with silver nitrate to obtain the corresponding nitrate ester derivatives.
The administered dose rate for paracetamol is preferably from 150 - 400 mg/hr.
The present invention relates to an oral pharmaceutical suspension comprising paracetamol and ibuprofen.
For enhancing stability the formulation contains a sulphur containing antioxidant, preferably sodium metabisulfite.
The object of the invention is an ophthalmic composition containing between 0.1 to 10 % by weight of paracetamol in an ophthalmic excipient.
A medicament tablet contains paracetamol as the (or an) active ingredient, and an encapsulated flavorant.
The present invention relates to compositions comprising a nitric oxide releasing paracetamol and an anticonvulsant drug.
The activity of Paracetamol increases after dissolution in aqueous form & make the patient more comfortable.
The invention relates to the formulation of an orodispersible tablet based on the active ingredient coated paracetamol acid with different dosages.
The invention is particularly, although not exclusively, concerned with treating or preventing liver damage caused by paracetamol poisoning.
A liquid formulation for intravenous infusion comprising tramadol and paracetamol in a non-deoxygenated aqueous solvent.